Schröder R, O'Brien P Q, Davis P L. "一种的合成方法" [P]. US Patent, US 10570610 B2, 2017-11-08.
发明人韩伟,郑宇鹏,郭海燕. "Method for the Synthesis of (S)-2-(3-Isobutyl-5-oxopiperazin-1-yl)acetic acid" [P]. 中国发明专利, 专利号 CN 108791536 A, 授权公告日 2024-05-28.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2017, 379, 3827-3847.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2020, 1295, (3), 1094-1106.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of (S)-2-(3-Isobutyl-5-oxopiperazin-1-yl)acetic acid Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2022, 1901, (1), 535-563.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2024, 589, (8), 441-454.